戻る Agenda
Sustaining Regulatory Systems in Africa – The Value of Reliance and Collaboration
Session Chair(s)
Sarah Adam
Associate Director, Regulatory Affairs
IFPMA, Switzerland
Agnès Saint-Raymond, DrMed
Head of Division International Affairs
European Medicines Agency, Netherlands
An update on the regional effort occurring in Africa to set up the new AMA from the lenses of the COVID-19 pandemic and its impact on the regulatory work in the continent
Learning Objective : Raise awareness in Europe of what ‘s happening in the regulatory field in Africa including the establishment of AMA. Share experience from the new ways of working under COVID-19 and identify opportunities for enhanced collaboration that can show the way forward.
Speaker(s)
AMRH, RECs, AMA (Progress, Current Status, Transition)
Paul Kiptum Tanui, MBA, RPh
The New Partnership For Africa's Development (NEPAD), South Africa
Senior Programme Officer, African Medicines Regulatory Harmonization Programme
Reliance and International Collaboration In Practice
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Panel Discussion Moderated by:
David Mukanga, PhD, MPH
Bill & Melinda Gates Foundation, United States
Deputy Director, Africa Regulatory Systems
Panelist
Paul Kiptum Tanui, MBA, RPh
The New Partnership For Africa's Development (NEPAD), South Africa
Senior Programme Officer, African Medicines Regulatory Harmonization Programme
Panelist
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Panelist
Samvel Azatyan, MD, PhD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Senior Adviser
Panelist
Kawaldip Sehmi
International Alliance Of Patients' Organizations (IAPO), United Kingdom
CEO
Panelist
Fabienne Y. Benoist, PhD, MPH
DNDi, Switzerland
Head of Regulatory Affairs
Panelist
Delese Mimi Darko, MBA, RPh, RAC
African Medicines Agency (AMA) , Ethiopia
Director General
Panelist
Sarah Adam
IFPMA, Switzerland
Associate Director, Regulatory Affairs